← Leaderboards
Benjamin D. Hopkins
Weill Medical Coll Of Cornell Univ
$826,078
Attributed
$826,078
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2018–21$250K$187.5K$125K$62.5K$0
'18
'19
'20
'21
Funding mix
By agency
NIH$826,078 · 2
By mechanism
R00$718,218 · 1
K99$107,860 · 1
Top collaborators
No co-investigators on record.
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Eduardo Francisco Gallo$2,429,294
- Evan K. Noch$855,251
- Marcus Dasilva Goncalves$8,791,437
- Whitney Juliet Sisso$98,512
- Federico Gaiti$212,432
Others in their field
Other Emerging Leaders on “Acute”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$51,003,204
- Julie Ake · National Institute Of Allergy And Infectious Diseases$41,692,120
- Xinhua Li · Nano Terra, Inc.$29,991,620
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$29,269,420
- Evan Z Macosko · Broad Institute, Inc.$27,107,011
Research focus
AcuteIndividual ResponseBaseBiochemicalAgreementBlood GlucoseCell Cycle ProgressionCell LineClinical DevelopmentClinical TrialsCollaborationsData SetDrug CombinationsDrug ScreeningDrug SensitivityFeedbackFutureGenetically Engineered MouseGenomic ApproachGenomicsGlucoseHot SpotHyperglycemiaInfancy
Grant awards (4)
Utilizing Precision Medicine to elucidate the mechanisms underpinning treatment efficacy$220,218
R00 · FY2021 · CA · contact PI
Utilizing Precision Medicine to elucidate the mechanisms underpinning treatment efficacy$249,000
R00 · FY2020 · CA · contact PI
Utilizing Precision Medicine to elucidate the mechanisms underpinning treatment efficacy$249,000
R00 · FY2019 · CA · contact PI
Utilizing Precision Medicine to elucidate the mechanisms underpinning treatment efficacy$107,860
K99 · FY2018 · CA · contact PI